|
WO2021081504A1
|
|
System, method, and computer-accessible medium for visualization and analysis of electroencephalogram oscillations in the alpha band
|
|
US2021123052A1
|
|
Methods for the in vivo production of single stranded dna and uses thereof
|
|
WO2021081373A1
|
|
Systems and methods for opening tissues
|
|
WO2021081156A1
|
|
Transgenic swine, methods of making and uses thereof, and methods of making human immune system mice
|
|
US2021126522A1
|
|
Methods, systems, and devices for soft switching of power converters
|
|
WO2021080922A1
|
|
Methods of performing rna templated genome editing
|
|
WO2021077042A1
|
|
Fiber-based scaffolds for tendon cell migration and regeneration
|
|
WO2021072405A1
|
|
System, method and computer-accessible medium for anesthesia monitoring using electroencephalographic monitoring
|
|
WO2021072361A1
|
|
Gene editing to correct aneuploidies and frame shift mutations
|
|
WO2021067914A1
|
|
Combination therapy for acute myeloid leukemia, myelodysplastic syndromes and other blood diseases and disorders
|
|
WO2021062261A1
|
|
Prognostic markers of metastatic cancer
|
|
US2021068663A1
|
|
Devices, compositions and methods for imaging with raman scattering and for super-multiplex vibrational imaging
|
|
WO2021055502A1
|
|
Identification of compounds that inhibit stress granule formation and tau aggregation by targeting tia1
|
|
WO2021050490A1
|
|
Methods of enhancing radiotherapy using ferroptosis inducers as radiosensitizers
|
|
WO2021050404A1
|
|
Microneedles to deliver therapeutic agent across membranes background of the disclosed subject matter
|
|
WO2021046398A2
|
|
Combination antiviral therapy for measles
|
|
WO2021042045A1
|
|
Methods for scalable gene insertions
|
|
WO2021041473A1
|
|
Engineered exosomes for targeted delivery
|
|
WO2021041509A1
|
|
Algorithm for the identification and phenotyping of nonalcoholic fatty liver disease patients
|
|
WO2021035208A1
|
|
Limb motion tracking biofeedback platform and method of rehabilitation therapy for patients with spasticity
|
